Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis by Michele Bottosso, Christian Zurlo, Federica Miglietta, Anna Chiara Cattelan, Daniela Iannaccone, Maria Vittoria Dieci, Gaia Griguolo, Fabio Girardi, Valentina Guarneri

Subjects: “…BRCA1/2…”
Get full text

Revisiting the molecular landscape of Rosai-Dorfman disease: insights from whole exome sequencing of Saudi patients by Sarah Binhassan, Sarah Binhassan, Manar Samman, Yazeed Al-Sheikh, Wafaa Alshakweer, Tahani Alhalouli, Najd Alshamlan, Manal Abudawood, Manal Abudawood

Subjects: Get full text

Mutational spectrum and profile of breast and ovarian cancer patients in Saudi Arabia’s western region: single center experience by Samar N. Ekram, Omima Elemam, Munzir Alandonisi, Arwa Flemban, Jamil Samkari, Hassan H. Zainuddin, Zohor Azher, Emad Tashkandi, Ahmad Mufti, Asim Khogeer

Subjects: Get full text

OVARIAN CANCER IN PATIENTS WITH BRCA1 5382insC MUTATION by А. B. Villert, L. А. Kolomiets, N. S. Rodicheva, А. А. Ivanova, N. V. Cherdyntseva, S. L. Stukanov

Subjects: Get full text

The spectrum of BRCA1 gene mutations in early onset breast cancer patients from Russia by M. S. Anisimenko, G. A. Paul, A. E. Kozyakov, N. I. Gutkina, D. A. Berdyugina, A. Yu. Garanin, A. V. Butorina, E. V. Gornostaeva, K. F. Khafizov, Yu. V. Vyatkin, D. N. Shtokalo, S. P. Kovalenko

Subjects: “…brca1 gene…”
Get full text

Araçá-Boi Extract and Gallic Acid Reduce Cell Viability and Modify the Expression of Tumor Suppressor Genes and Genes Involved in Epigenetic Processes in Ovarian Cancer by Felipe Tecchio Borsoi, Henrique Silvano Arruda, Amanda Cristina Andrade, Mônica Pezenatto dos Santos, Isabelle Nogueira da Silva, Leonardo Augusto Marson, Ana Sofia Martelli Chaib Saliba, Severino Matias de Alencar, Murilo Vieira Geraldo, Iramaia Angélica Neri Numa, Glaucia Maria Pastore

Subjects: Get full text

BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovaria... by Heidelinde Fiegl, Simon Schnaiter, Daniel U. Reimer, Katharina Leitner, Petra Nardelli, Irina Tsibulak, Verena Wieser, Katharina Wimmer, Esther Schamschula, Christian Marth, Alain G. Zeimet

Subjects: Get full text

Genetic factors for breast carcinogenesis by Pedro Enrique Miguel-Soca, Ivis Argüelles González, Marisol Peña González

Subjects: Get full text

Clinicopathological Characteristics of HER2-Positive Breast Cancer Patients with BRCA1/2 Pathogenic Variants and Their Response to Neoadjuvant Targeted Therapy by Xingyu LIAO, Huimin LIU, Jie SUN, Li HU, Juan ZHANG, Lu YAO, Ye XU, Yuntao XIE

Subjects: “…brca1/2 pathogenic variant…”
Get full text

Molecular analysis of BRCA1 and BRCA2 genes in La Rioja (Spain): five new variants by Raquel Salazar Saez, Miriam Zorrilla, Rosa Sánchez, Ana Cebollero, Isabel Manrique, Alfonso Martín, Leticia de Ávila, Alejandra Lacalle-Emborujo, Samuel Martin-Rodriguez, Iván Bernardo-González, Martina Alonso

Subjects: “…BRCA1…”
Get full text

Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion by Monique G.P. van der Wijst, Christian Huisman, Archibold Mposhi, Gerard Roelfes, Marianne G. Rots

Subjects: Get full text

Frecuencia de las mutaciones en los genes BRCA en mujeres con agregación familiar de cáncer de glándula mamaria/ovario by Jennyfer Dahianna Benavides-Cerquera, Mabel Elena Bohórquez-Lozano, Carlos Fernando Prada-Quiroga, Luis Carvajal-Carmona, María Magdalena Echeverry de Polanco

Subjects: Get full text

Carcinogenic potential of ovulation stimulation in BRCA1/2 gene mutation carriers in assisted reproductive technology programs by Lidia A. Klyukina, Elena A. Sosnova, Anton A. Ishchenko

Subjects: Get full text

Experience in the use of olaparib poly (ADP-ribose) polymerase inhibitors in maintenance therapy of BRCA-associated ovarian cancer by V. N. Zhurman, V. M. Nechushkina

Subjects: Get full text

Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation by Piera Grisolia, Rossella Tufano, Clara Iannarone, Antonio De Falco, Francesca Carlino, Cinzia Graziano, Raffaele Addeo, Marianna Scrima, Francesco Caraglia, Anna Ceccarelli, Pier Vitale Nuzzo, Alessia Maria Cossu, Stefano Forte, Raffaella Giuffrida, Michele Orditura, Michele Caraglia, Michele Ceccarelli

Subjects: Get full text

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER by M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, N. V. Litviakov

Subjects: Get full text

Case Report: Influence of BRCA1 germline mutation on treatment-related morbidity of a non-seminomatous germ cell tumor patient by Bruno Griesler, Bruno Griesler, Susann Schulze, Thomas Kegel, Christine Dierks, Pablo Villavicencio-Lorini, Pablo Villavicencio-Lorini, Markus Eszlinger, Haifa Kathrin Al-Ali, Nadja Jaekel

Subjects: Get full text

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER by K. B. Kotiv, T. V. Gorodnova, A. O. Ivantsov, A. G. Iyevleva, S. N. Aleksakhina, G. M. Manichas, A. S. Lisyanskaya, R. P. Salomatov, M. S. Shushaniia, M. V. Borodenko, L. D. Roman, G. I. Mikhailiuk, O. N. Mikheeva, T. G. Grigorieva, I. V. Berlev, E. N. Imyanitov, A. P. Sokolenko

Subjects: Get full text

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER by S. A. Laptiev, M. A. Korzhenevskaia, A. P. Sokolenko, A. G. Iyevleva, E. N. Imyanitov

Subjects: Get full text

Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis by Shihao Sun, Shuang Chen, Kaiyuan Li, Ge Zhang, Ge Zhang, Ge Zhang, Nan Wang, Yijia Xu, Xinxing Wang, Jiangrui Chi, Lin Li, Yi Sun

Subjects: Get full text